VB10.COV-2 vaccine: Clinical Trials

1 trial of VB10.COV-2 vaccine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow VB10.COV-2 vaccine: new trials by email Literature Review of VB10.COV-2 vaccine trials Research Report on VB10.COV-2 vaccine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
VB10.2129, VB10.2210 - COVID-19, Infection Viral
Phase 1 / Phase 2CompletedNykode Therapeutics ASA682021-11-012024-04-11

Conditions studied

COVID-19 (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Virus Diseases (1)

Sponsors

Nykode Therapeutics ASA (1)

Countries

Norway (1)